The real-life findings showed that treatment with brodalumab improved health-related quality of life (HRQOL) for patients but itching prevented complete improvement. Despite achieving clear or almost ...

Higher disease acceptance in patients with psoriasis is linked to better outcomes, underscoring the need for psychological resilience in treatment. The study found illness acceptance negatively ...

Please provide your email address to receive an email when new articles are posted on . Arcutis Biotherapeutics announced positive results from two pivotal phase 3 studies evaluating Zoryve cream as a ...

Please provide your email address to receive an email when new articles are posted on . Patient reported data from two phase 3 trials found roflumilast cream 0.3% significantly reduced itch severity ...

More than eight million people in the United States have the autoimmune skin condition known as psoriasis, according to the National Psoriasis Foundation. Psoriasis is a chronic condition. There’s no ...

DENVER — The topical TrkA kinase inhibitor CT327 reduces chronic itch in patients with psoriasis, according to results from a new study. "This is an unmet need," said Gil Yosipovitch, MD, professor of ...

By Sriparna Roy March 18 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's oral pill for psoriasis, the company said on Wednesday, paving the way for a more convenient ...

Can what you eat help calm psoriasis, a chronic inflammatory disease that affects the skin? It's identified by the development of thick, red patches with silvery scales, causing the area to itch or ...

From itchy skin to ongoing stress and anxiety, psoriasis symptoms can make getting a good night’s sleep difficult. As many as 50 percent of people with psoriasis have sleep problems at least once a ...